InsiderClue
Insiders · Profile

MENDLEIN JOHN

Director at FATE THERAPEUTICS · Director at aTYR PHARMA. Filing since 4 Oct 2013. CIK 0001238362

FATE FATE THERAPEUTICS INC Director · 5 trades ATYR aTYR PHARMA INC Director · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
FATE FATE THERAPEUTICS INC
13 Jan 2023
Director
Bought
36,631
$198.91K
14.9%
FATE FATE THERAPEUTICS INC
11 Jan 2023
Director
Bought
88,048
$499.23K
55.7%
FATE FATE THERAPEUTICS INC
3 Jun 2022
Director
Sold, plan not stated
1,364
$31.09K
0.9%
FATE FATE THERAPEUTICS INC
10 Mar 2022
Director
Sold, plan not stated
31,562
$1.11M
16.5%
ATYR aTYR PHARMA INC
21 Dec 2018
Director
Bought
195,000
$82.60K
46.4%
ATYR aTYR PHARMA INC
20 Dec 2018
Director
Bought
50,000
$20.65K
13.5%
ATYR aTYR PHARMA INC
31 Aug 2017
CEO and Director
Bought
37,736
$100.00K
11.4%
ATYR aTYR PHARMA INC
24 Apr 2017
CEO and Director
Bought
124
$372.00
0.0%
ATYR aTYR PHARMA INC
20 Apr 2017
CEO and Director
Bought
1,552
$4.66K
0.5%
ATYR aTYR PHARMA INC
18 Apr 2017
CEO and Director
Bought
1,000
$3.00K
0.3%
ATYR aTYR PHARMA INC
19 Dec 2016
CEO and Director
Bought
69,000
$151.66K
27.0%
ATYR aTYR PHARMA INC
5 Apr 2016
CEO and Director
Bought
5,000
$17.68K
2.0%
FATE FATE THERAPEUTICS INC
4 Oct 2013
Director
Bought
16,667
$100.00K
11.9%
13 decisions on file.